ROMANO BROTHERS AND COMPANY

Position in NVS — Novartis AG

CIK 200648 EVANSTON, IL

Position in NVS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$1,065,225

+$19,346 QoQ

Shares Held

6,797

-0.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#598

of 1,603 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ROMANO BROTHERS AND COMPANY holds $67,540,933 across 10 Drug Manufacturers - General names. NVS ranks #9 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	123,458	$31,066,971
2	JNJ	Johnson & Johnson	34,233	$8,694,155
3	AMGN	Amgen Inc	19,859	$7,191,341
4	LLY	ELI LILLY & Co	5,634	$6,757,589
5	MRK	Merck & Co., Inc.	43,197	$5,550,814
6	BMY	Bristol Myers Squibb Co	46,486	$2,678,523
7	GILD	Gilead Sciences, Inc.	15,921	$2,011,459
8	PFE	Pfizer Inc	69,523	$1,674,113

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,065,225	6,797	-0.7%	Shares	Sole	2026-07-22
2026-03-31	$1,045,879	6,847	+0.1%	Shares	Sole	2026-04-22
2025-12-31	$943,444	6,843	-2.8%	Shares	Sole	2026-01-14
2025-09-30	$903,194	7,043	0.0%	Shares	Sole	2025-10-21
2025-06-30	$852,273	7,043	+0.1%	Shares	Sole	2025-07-22
2025-03-31	$784,484	7,037	-3.8%	Shares	Sole	2025-04-10
2024-12-31	$711,530	7,312	0.0%	Shares	Sole	2025-01-16
2024-09-30	$841,026	7,312	-0.7%	Shares	Sole	2024-10-22
2024-06-30	$783,758	7,362	+0.1%	Shares	Sole	2024-07-17
2024-03-31	$711,545	7,356	0.0%	Shares	Sole	2024-04-17
2023-12-31	$742,735	7,356	-3.0%	Shares	Sole	2024-01-29
2023-09-30	$772,200	7,581	-0.7%	Shares	Sole	2023-10-17
2023-06-30	$770,044	7,631	+0.0%	Shares	Sole	2023-07-13
2023-03-31	$701,960	7,630	-2.2%	Shares	Sole	2023-04-13
2022-12-31	$707,616	7,800	0.0%	Shares	Sole	2023-01-18
2022-09-30	$592,878	7,800	—	Shares	Sole	2022-10-18
No filing history on record for this holder in this stock.